Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties
Luca Gallelli1,2 1Department of Health Science, School of Medicine, University of Catanzaro, Catanzaro, Italy; 2Operative Unit of Clinical Pharmacology and Pharmacovigilance, Azienda Ospedaliera Mater Domini, Catanzaro, ItalyCorrespondence: Luca GallelliOperative Unit of Clinical Pharmacology and Ph...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-09-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/escin-a-review-of-its-anti-edematous-anti-inflammatory-and-venotonic-p-peer-reviewed-article-DDDT |
id |
doaj-29ffa8915bd94738b9bf0af1187b1345 |
---|---|
record_format |
Article |
spelling |
doaj-29ffa8915bd94738b9bf0af1187b13452020-11-25T02:39:33ZengDove Medical PressDrug Design, Development and Therapy1177-88812019-09-01Volume 133425343748856Escin: a review of its anti-edematous, anti-inflammatory, and venotonic propertiesGallelli LLuca Gallelli1,2 1Department of Health Science, School of Medicine, University of Catanzaro, Catanzaro, Italy; 2Operative Unit of Clinical Pharmacology and Pharmacovigilance, Azienda Ospedaliera Mater Domini, Catanzaro, ItalyCorrespondence: Luca GallelliOperative Unit of Clinical Pharmacology and Pharmacovigilance, Azienda Ospedaliera Mater Domini, Viale Tommaso Campanella 115, Catanzaro 88100, ItalyTel +39 96 171 2322Fax +39 96 177 4424Email gallelli@unicz.itAbstract: This review discusses historical and recent pharmacological and clinical data on the anti-edematous, anti-inflammatory, and venotonic properties of escin (Reparil®). Escin, the active component of Aesculus hippocastanum, or horse chestnut, is available as orally absorbable dragées and as a transdermal gel. The anti-inflammatory and anti-edematous effects of escin have been studied over many years in pre-clinical models. More recent data confirm the anti-inflammatory properties of escin in reducing vascular permeability in inflamed tissues, thereby inhibiting edema formation. The venotonic effects of escin have been demonstrated primarily by in vitro studies of isolated human saphenous veins. The ability of escin to prevent hypoxia-induced disruption to the normal expression and distribution of platelet endothelial cell-adhesion molecule-1 may help explain its protective effect on blood vessel permeability. Escin oral dragées and transdermal gel have both demonstrated efficacy in blunt trauma injuries and in chronic venous insufficiency. Both oral escin and the transdermal gel are well tolerated.Keywords: blunt trauma, chronic venous insufficiency, edema, escin, pain, Reparil®https://www.dovepress.com/escin-a-review-of-its-anti-edematous-anti-inflammatory-and-venotonic-p-peer-reviewed-article-DDDTblunt traumachronic venous insufficiencyedemaescinpainReparil® |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Gallelli L |
spellingShingle |
Gallelli L Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties Drug Design, Development and Therapy blunt trauma chronic venous insufficiency edema escin pain Reparil® |
author_facet |
Gallelli L |
author_sort |
Gallelli L |
title |
Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties |
title_short |
Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties |
title_full |
Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties |
title_fullStr |
Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties |
title_full_unstemmed |
Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties |
title_sort |
escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties |
publisher |
Dove Medical Press |
series |
Drug Design, Development and Therapy |
issn |
1177-8881 |
publishDate |
2019-09-01 |
description |
Luca Gallelli1,2 1Department of Health Science, School of Medicine, University of Catanzaro, Catanzaro, Italy; 2Operative Unit of Clinical Pharmacology and Pharmacovigilance, Azienda Ospedaliera Mater Domini, Catanzaro, ItalyCorrespondence: Luca GallelliOperative Unit of Clinical Pharmacology and Pharmacovigilance, Azienda Ospedaliera Mater Domini, Viale Tommaso Campanella 115, Catanzaro 88100, ItalyTel +39 96 171 2322Fax +39 96 177 4424Email gallelli@unicz.itAbstract: This review discusses historical and recent pharmacological and clinical data on the anti-edematous, anti-inflammatory, and venotonic properties of escin (Reparil®). Escin, the active component of Aesculus hippocastanum, or horse chestnut, is available as orally absorbable dragées and as a transdermal gel. The anti-inflammatory and anti-edematous effects of escin have been studied over many years in pre-clinical models. More recent data confirm the anti-inflammatory properties of escin in reducing vascular permeability in inflamed tissues, thereby inhibiting edema formation. The venotonic effects of escin have been demonstrated primarily by in vitro studies of isolated human saphenous veins. The ability of escin to prevent hypoxia-induced disruption to the normal expression and distribution of platelet endothelial cell-adhesion molecule-1 may help explain its protective effect on blood vessel permeability. Escin oral dragées and transdermal gel have both demonstrated efficacy in blunt trauma injuries and in chronic venous insufficiency. Both oral escin and the transdermal gel are well tolerated.Keywords: blunt trauma, chronic venous insufficiency, edema, escin, pain, Reparil® |
topic |
blunt trauma chronic venous insufficiency edema escin pain Reparil® |
url |
https://www.dovepress.com/escin-a-review-of-its-anti-edematous-anti-inflammatory-and-venotonic-p-peer-reviewed-article-DDDT |
work_keys_str_mv |
AT gallellil escinareviewofitsantiedematousantiinflammatoryandvenotonicproperties |
_version_ |
1724785428955922432 |